If you've seen our related video on this topic, you already know that bile duct cancer in a military veteran can be the result of service in Vietnam. In this video, find out more about winning service connection for this serious disease.

Hello friends I am Dr. Vineet Gautam, Surgical Gastroenterologist, Gastro Oncosurgeon, and liver transplant surgeon at GBL Hospital Indore. We are coming up with another video of our series to help patients to know more about the problems related to the complex diseases of the digestive system. In this video, we are trying to cover the Causes, Complications & Treatment of "Bile Duct Cancer"

Hi folks! Welcome back to TYP. It's me, Megan, here with an update on my cancer-fighting journey. Every three months, I attend a "re-staging" appointment with my oncologist to review my progress and treatment regimen. Today, I'm here with an update from my latest re-staging appointment. In this video, I'll talk about CT and MRI scans, my new chemotherapy regimen (including expected side effects), and my latest biopsy experience. Plus, I'll talk about some potential treatment options we're exploring with PARP inhibitors and more (fingers crossed!). Thank you so much for watching and for your support!

Want to join our new community for younger people with terminal illnesses and their loved ones? Email Megan at terminalyetpurposeful@gmail.com

Mayo Clinic hepatobiliary surgeon, Rory Smoot, M.D., discusses cholangiocarcinoma, or cancer of the bile ducts. He explains treatment options and the specialized team of experts at Mayo Clinic who provide care for patients with cholangiocarcinoma.

For more information on cholangiocarcinoma, visit http://www.mayoclinic.org/diseases-conditions/bile-duct-cancer/diagnosis-treatment/expertise-ranking/orc-20202935?mc_id=us&utm_source=youtube&utm_medium=sm&utm_content=video&utm_campaign=mayoclinic&geo=national&placementsite=enterprise&cauid=100504

Lorenza Rimassa, MD, Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy, explains the basics of cholangiocarcinoma, including the incidence, survival rates, and current treatment landscape for patients with early-stage and advanced disease. Chemotherapy is a key part of treatment for patients with advanced cholangiocarcinoma, but the recent Phase III TOPAZ-1 trial (NCT03875235) reported positive results for the addition of durvalumab to first-line chemotherapy for these patients. Dr Rimassa also discusses recent research into novel targeted treatments for cholangiocarcinoma. This interview took place at the European Society for Medical Oncology World Congress on Gastrointestinal Cancer (ESMO WCGIC) 2022 in Barcelona, Spain.

Prashant Kedia, MD, Medical Director of the Methodist Interventional Endoscopy Center of Excellence, explains how physicians at the Center can examine the gastrointestinal (GI) system with a specialized endoscope to diagnose and often treat disease. This includes removing obstructions, destroying cancerous tumors, and performing laser therapies, all without making an incision.